| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,068,000 | 2,036,000 | 1,819,000 | 1,979,000 | | Cost of Revenue | 1,499,000 | 1,490,000 | 1,403,000 | 1,581,000 | | | Gross Profit | 569,000 | 546,000 | 416,000 | 398,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 423,000 | 434,000 | 423,000 | 422,000 | | Non Recurring |
-
|
-
|
-
| 467,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 146,000 | 112,000 | (7,000) | (491,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,000 | 8,000 | (3,000) | (32,000) | | Earnings Before Interest And Taxes | 153,000 | 120,000 | (10,000) | (523,000) | | Interest Expense | 56,000 | 57,000 | 56,000 | 56,000 | | Income Before Tax | 97,000 | 63,000 | (66,000) | (579,000) | | Income Tax Expense | 26,000 | 1,000 | 8,000 | (75,000) | | Minority Interest | (27,000) |
-
|
-
| (4,000) | | | | Net Income From Continuing Ops | 44,000 | 62,000 | (74,000) | (508,000) | | | Non-recurring Events | | Discontinued Operations | (31,000) | 1,000 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,000 | 63,000 | (74,000) | (508,000) | | Preferred Stock And Other Adjustments | 15,000 | (8,000) | (7,000) |
-
| | | Net Income Applicable To Common Shares | $28,000 | $55,000 | ($81,000) | ($508,000) |
|
1.23% Nasdaq 
Income Statement
